Molecular signatures of metaplastic carcinoma of the breast by large-scale transcriptional profiling: identification of genes potentially related to epithelial–mesenchymal transition

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Oncogene

• Publication date

  2007-12-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1210593PMID 17603561
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The epithelial–mesenchymal transition: new insights in signaling, development, and disease

  2006cited by this paper
• An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen

  2006cited by this paper
• Metaplastic carcinoma of the breast Clinical presentation, treatment results and prognostic factors

  2006cited by this paper
• Spindle Cell (Sarcomatoid) Carcinoma of the Breast: A Clinicopathologic and Immunohistochemical Analysis of 29 Cases

  2006influential reference
• Critical molecular switches involved in BMP-2-induced osteogenic differentiation of mesenchymal cells.

  2006cited by this paper
• Characteristics and Treatment of Metaplastic Breast Cancer: Analysis of 892 Cases from the National Cancer Data Base

  2006influential reference
• Autocrine PDGFR signaling promotes mammary cancer metastasis.

  2006cited by this paper
• PDGFR‐α signaling is critical for tooth cusp and palate morphogenesis

  2005cited by this paper
• ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro

  2005influential reference
• TGF-β and epithelial-to-mesenchymal transitions

  2005influential reference
• Proteolytic maturation and activation of autotaxin (NPP2), a secreted metastasis-enhancing lysophospholipase D

  2005cited by this paper
• Bmp2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning

  2005cited by this paper
• Reactivation of Hox gene expression during bone regeneration

  2005influential reference
• Metaplastic breast carcinoma: clinical–pathologic characteristics and HER2/neu expression

  2005influential reference
• The origin of vimentin expression in invasive breast cancer: epithelial–mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential?

  2005cited by this paper
• PDGFR-alpha signaling is critical for tooth cusp and palate morphogenesis.

  2005cited by this paper
• TGF-beta and epithelial-to-mesenchymal transitions.

  2005cited by this paper
• Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial–mesenchymal transition

  2004influential reference
• p53 overexpression and mutation in metaplastic carcinoma of the breast: genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components

  2004cited by this paper
• Recent translational research: microarray expression profiling of breast cancer – beyond classification and prognostic markers?

  2004influential reference
• Increased osteonectin expression is associated with malignant transformation and tumor associated fibrosis in the lung.

  2004cited by this paper
• SPARC and tumor growth: Where the seed meets the soil?

  2004influential reference
• Lumican expression is associated with the formation of mesenchyme‐like elements in salivary pleomorphic adenomas

  2004cited by this paper
• Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer.

  2004cited by this paper
• Rosai and Ackerman???s Surgical Pathology

  2004cited by this paper
• Novel and Classic Myoepithelial/Stem Cell Markers in Metaplastic Carcinomas of the Breast

  2003cited by this paper
• CRB3 binds directly to Par6 and regulates the morphogenesis of the tight junctions in mammalian epithelial cells.

  2003cited by this paper
• Tissue and plasma expression of the angiogenic peptide adrenomedullin in breast cancer

  2003cited by this paper
• Response of lens epithelial cells to injury: role of lumican in epithelial-mesenchymal transition.

  2003cited by this paper
• CCAAT/enhancer binding protein beta (C/EBPβ)-2 transforms normal mammary epithelial cells and induces epithelial to mesenchymal transition in culture

  2003cited by this paper
• Differential gene expression of TGF-beta family members and osteopontin in breast tumor tissue: analysis by real-time quantitative PCR.

  2002cited by this paper
• Epithelial–mesenchymal transitions in tumour progression

  2002cited by this paper
• Differential Gene Expression of TGF-β Family Members and Osteopontin in Breast Tumor Tissue: Analysis by Real-Time Quantitative PCR

  2002cited by this paper
• Epiplakin, a Novel Member of the Plakin Family Originally Identified as a 450-kDa Human Epidermal Autoantigen

  2001cited by this paper
• Del1: a new protein in the superficial layer of articular cartilage.

  2001influential reference
• Human junction adhesion molecule regulates tight junction resealing in epithelia.

  2000cited by this paper
• Gene Ontology: tool for the unification of biology

  2000cited by this paper
• Loss of expression of the candidate tumor suppressor gene ZAC in breast cancer cell lines and primary tumors

  1999cited by this paper
• Antiproliferatiye effects of recombinant human bone morphogenetic protein‐2 on human tumor colony‐forming units

  1998cited by this paper
• Identical clonality of both components of mammary carcinosarcoma with differential loss of heterozygosity.

  1997cited by this paper
• Complete coding sequence and deduced primary structure of the human cartilage large aggregating proteoglycan, aggrecan. Human-specific repeats, and additional alternatively spliced forms.

  1991influential reference

• Identification of Common Cancer Antigens Useful for Specific Immunotherapies to Colorectal Cancer and Liver Metastases

  2025cites this paper
• Molecular Subtypes and Biomarker-based Detection of Breast Cancer: Challenges and Future Perspectives

  2025cites this paper
• Repurposing FDA-approved drugs to target G-quadruplexes in breast cancer.

  2025cites this paper
• Metaplastic carcinoma of breast with heterologous mesenchymal differentiation (carcinosarcoma) having an endothelial component: a case report

  2025cites this paper
• Histopathological Spectrum of Metaplastic Carcinoma of the Breast: A Rare Case Series and a Review of Literature

  2025cites this paper
• Therapeutic strategies and landscape of metaplastic breast cancer.

  2025cites this paper
• Neoadjuvant Chemotherapy is Not Associated with Improved Overall Survival in Metaplastic Breast Cancer Regardless of Tumor Subtype

  2025cites this paper
• Identification of 68 HLA-A24 and -A2-restricted cytotoxic T lymphocyte-inducing peptides derived from 10 common cancer-specific antigens frequently expressed in various solid cancers

  2025cites this paper
• An update on existing therapeutic options and status of novel anti-metastatic agents in breast cancer: Elucidating the molecular mechanisms underlying the pleiotropic action of Withania somnifera (Indian ginseng) in breast cancer attenuation.

  2024cites this paper
• Translational Aspects in Metaplastic Breast Carcinoma

  2024influential citation
• Analysis of clinicopathological characteristics and prognostic factors in 54 metaplastic breast carcinoma patients from northwest China

  2024cites this paper
• Метапластическая карцинома молочной железы. Подходы к морфологической диагностике. Обзор литературы

  2024cites this paper
• Stromal Signals Dominate Gene Expression Signature Scores That Aim to Describe Cancer Cell–intrinsic Stemness or Mesenchymality Characteristics

  2023cites this paper
• Glucose oxidase virus‐based nanoreactors for smart breast cancer therapy

  2023cites this paper
• Epithelial to mesenchymal transition (EMT) in metaplastic breast cancer and phyllodes breast tumors

  2023cites this paper
• Transcriptomic alterations underlying metaplasia into specific metaplastic components in metaplastic breast carcinoma

  2023cites this paper
• [Elucidation of Drug Transport Mechanism by Serum Protein and Development for Pancreatic Cancer Treatment].

  2023cites this paper
• An Overview of Epithelial-to-Mesenchymal Transition and Mesenchymal-to-Epithelial Transition in Canine Tumors: How Far Have We Come?

  2022cites this paper
• GATA3 Truncation Mutants Alter EMT Related Gene Expression via Partial Motif Recognition in Luminal Breast Cancer Cells

  2022cites this paper
• Male metaplastic breast cancer with poor prognosis: A case report

  2022cites this paper
• Establishment of prognostic model for postoperative patients with metaplastic breast cancer: Based on a retrospective large data analysis and Chinese multicenter study

  2022cites this paper
• Invasive lobular carcinoma with extracellular mucin (ILCEM): clinicopathologic and molecular characterization of a rare entity

  2022cites this paper
• Molecular characterization and prospective evaluation of pathological response and outcomes with neoadjuvant therapy in metaplastic triple-negative breast cancer.

  2022cites this paper
• Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma

  2021cites this paper
• The Role of Adjuvant Chemotherapy in Metaplastic Breast Carcinoma: A Competing Risk Analysis of the SEER Database

  2021cites this paper
• SPARC Overexpression Promotes Liver Cancer Cell Proliferation and Tumor Growth

  2021cites this paper
• MicroRNA-495/TGF-β/FOXC1 axis regulates multidrug resistance in metaplastic breast cancer cells.

  2021cites this paper
• Modulating gene expression in breast cancer via DNA secondary structure and the CRISPR toolbox

  2021cites this paper
• Construction and Validation of a Prognostic Model for the Assessment of Postoperative Overall Survival of Patients with Metaplastic Breast Cancer: Based on a Retrospective Large Data Analysis and Chinese Multicenter Study

  2021cites this paper
• Single‐cell RNA sequencing reveals the epithelial cell heterogeneity and invasive subpopulation in human bladder cancer

  2021cites this paper
• Epithelial Mesenchymal Transition and Immune Response in Metaplastic Breast Carcinoma

  2021cites this paper
• Mammary-specific expression of Trim24 establishes a mouse model of human metaplastic breast cancer

  2021cites this paper
• A Case of Rare Matrix-producing Triple-negative Breast Carcinoma for Which Drug Response in a Patient-derived Orthotopic Xenograft Mouse Model Was Correlated With Patient Response

  2021cites this paper
• Spindle cell lesions of the breast: a diagnostic approach

  2021cites this paper
• Downregulation of SPARC Expression Decreases Cell Migration and Invasion Involving Epithelial-Mesenchymal Transition through the p-FAK/p-ERK Pathway in Esophageal Squamous Cell Carcinoma

  2020cites this paper
• Metaplastic carcinoma of breast: a report of two cases

  2020cites this paper
• The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas

  2020cites this paper
• Molecular Features of Metaplastic Breast Carcinoma: An Infrequent Subtype of Triple Negative Breast Carcinoma

  2020cites this paper
• Comparison of outcomes between metaplastic and triple-negative breast cancer patients

  2019cites this paper
• The subpopulation of CD44-positive cells promoted tumorigenicity and metastatic ability in lung adenocarcinoma

  2019cites this paper
• Metaplastic Carcinoma of the Breast: Analysis of 38 Cases from a Single Institute

  2019cites this paper
• Has2 natural antisense RNA and Hmga2 promote Has2 expression during TGFβ-induced EMT in breast cancer.

  2019cites this paper
• WWOX inhibits metastasis of triple-negative breast cancer cells via modulation of microRNAs

  2019influential citation
• Impact of Fibroblast-Derived SPARC on Invasiveness of Colorectal Cancer Cells

  2019cites this paper
• RAE1 mediated ZEB1 expression promotes epithelial–mesenchymal transition in breast cancer

  2019cites this paper
• Fibrillin-1, a novel TGF-beta-induced factor, is preferentially expressed in metaplastic carcinoma with spindle sarcomatous metaplasia.

  2019cites this paper
• WWOX Inhibits Metastasis of Triple-Negative Breast Cancer Cells via Modulation of miRNAs.

  2019cites this paper
• Pathway activity profiling of growth factor receptor network and stemness pathways differentiates metaplastic breast cancer histological subtypes

  2019cites this paper
• Comparative prognostic analysis for triple-negative breast cancer with metaplastic and invasive ductal carcinoma

  2019cites this paper
• A Soft Microenvironment Protects from Failure of Midbody Abscission and Multinucleation Downstream of the EMT-Promoting Transcription Factor Snail.

  2018cites this paper
• A Comparative Review of Mixed Mammary Tumors in Mammals

  2018cites this paper
• Analysis of potential driver genes in oral squamous cell carcinoma

  2018cites this paper
• The Clinicopathological Features and Survival Outcomes of Different Histological Subtypes in Triple-negative Breast Cancer

  2018cites this paper
• High N-Acetyltransferase 1 Expression is Associated with Estrogen Receptor Expression in Breast Tumors, but is not Under Direct Regulation by Estradiol, 5α-androstane-3β, 17β-Diol, or Dihydrotestosterone in Breast Cancer Cells

  2018cites this paper
• Role of Sparc as a Prognostic Factor in Pancreatic Tumors

  2018cites this paper
• Regulation of hyaluronan biosynthesis and clinical impact of excessive hyaluronan production.

  2018cites this paper
• Clinicopathological characteristics and prognosis of metaplastic carcinoma of the breast

  2017cites this paper
• Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer

  2017cites this paper
• Title : Expression of secreted protein acidic and rich in cysteine is an independent prognostic indicator of a poor clinical outcome in oropharyngeal carcinoma patients

  2017cites this paper
• Metaplastic breast carcinoma: Analysis of 31 cases from a single institute.

  2017cites this paper
• SPARC: As a prognostic biomarker in rectal cancer patients treated with chemo-radiotherapy

  2017cites this paper
• A Rational Drug Combination Design to Inhibit Epithelial-Mesenchymal Transition in a Three-Dimensional Microenvironment

  2017cites this paper
• Metaplastic Breast Cancer: Molecular Typing and Identification of Potential Targeted Therapies at a Single Institution

  2017influential citation
• Dramatic response of metaplastic breast cancer to chemo-immunotherapy

  2017cites this paper
• SPARC inhibits breast cancer bone metastasis and may be a clinical therapeutic target

  2017cites this paper
• Whole-Exome Sequencing of Metaplastic Breast Carcinoma Indicates Monoclonality with Associated Ductal Carcinoma Component

  2017cites this paper
• Expression of secreted protein acidic and rich in cysteine is an independent prognostic indicator of a poor clinical outcome in oropharyngeal carcinoma patients

  2016cites this paper
• Molekulare Marker zur Prädiktion des Ansprechens auf neoadjuvante Therapie beim Mammakarzinom

  2016cites this paper
• Impact of suppression of tumorigenicity 14 (ST14)/serine protease 14 (Prss14) expression analysis on the prognosis and management of estrogen receptor negative breast cancer

  2016cites this paper
• Epithelial-Mesenchymal Transition and Breast Cancer

  2016cites this paper
• Cardiotoxin III suppresses the invasiveness of MDA-MB-231 cells by targeting proto-oncogene tyrosine-protein kinase Src and reversing mesenchymal-to-epithelial transition

  2016influential citation
• Metaplastic carcinoma of the breast: A case series and review of the literature

  2016cites this paper
• TIMPs: versatile extracellular regulators in cancer

  2016cites this paper
• KRT19 directly interacts with β-catenin/RAC1 complex to regulate NUMB-dependent NOTCH signaling pathway and breast cancer properties

  2016cites this paper
• Title: Expression of secreted protein acidic and rich in cysteine is an independent prognostic indicator of a poor clinical outcome in oropharyngeal carcinoma patients

  2016cites this paper
• SPOCK1 Is a Novel Transforming Growth Factor-β–Induced Myoepithelial Marker That Enhances Invasion and Correlates with Poor Prognosis in Breast Cancer

  2016cites this paper
• Role of phytochemicals in the inhibition of epithelial-mesenchymal transition in cancer metastasis.

  2016cites this paper
• Predictive Outcomes for HER2-enriched Cancer Using Growth and Metastasis Signatures Driven By SPARC

  2016cites this paper
• EMT in Breast Carcinoma—A Review

  2016influential citation
• SPARC overexpression combined with radiation retards angiogenesis by suppressing VEGF-A via miR-410 in human neuroblastoma cells

  2016cites this paper
• PRRX2 as a novel TGF‐β‐induced factor enhances invasion and migration in mammary epithelial cell and correlates with poor prognosis in breast cancer

  2016cites this paper
• Meta-Analysis of Tumor Stem-Like Breast Cancer Cells Using Gene Set and Network Analysis

  2016cites this paper
• A Clinicopathologic Analysis of 45 Patients With Metaplastic Breast Carcinoma.

  2016cites this paper
• Breast carcinoma with a predominant duct-replacing component and chondroid matrix production

  2016cites this paper
• An approach to the diagnosis of spindle cell lesions of the breast

  2016cites this paper
• Expression of secreted protein acidic and rich in cysteine (SPARC) in breast cancer and response to neoadjuvant chemotherapy.

  2015cites this paper
• Metaplastic carcinoma show different expression pattern of YAP compared to triple-negative breast cancer

  2015cites this paper
• Metaplastic Breast Cancer: Clinical Overview and Molecular Aberrations for Potential Targeted Therapy

  2015cites this paper
• Cancer stem cell and epithelial–mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast

  2015cites this paper
• Metastatic metaplastic breast carcinoma mimicking pulmonary squamous cell carcinoma on fine‐needle aspiration

  2015cites this paper
• Phosphorylation of EZH2 at T416 by CDK2 contributes to the malignancy of triple negative breast cancers.

  2015cites this paper
• Enriched transcription factor signatures in triple negative breast cancer indicates possible targeted therapies with existing drugs

  2015cites this paper
• Genomic profiling of advanced-stage, metaplastic breast carcinoma by next-generation sequencing reveals frequent, targetable genomic abnormalities and potential new treatment options.

  2015cites this paper
• Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.

  2015cites this paper
• Molecular mechanisms underlying the divergent roles of SPARC in human carcinogenesis

  2014cites this paper
• MicroRNAs regulate both epithelial-to-mesenchymal transition and cancer stem cells

  2014cites this paper
• Mesenchymal-mode migration assay and antimetastatic drug screening with high-throughput microfluidic channel networks.

  2014cites this paper
• Molecular mechanisms underlying the divergent roles of SPARC in human carcinogenesis.

  2014cites this paper
• MicroRNA control of epithelial‐mesenchymal transition in cancer stem cells

  2014cites this paper
• Differential expression of hyaluronan synthase 2 in breast carcinoma and its biological significance

  2014cites this paper